Hemorrhage, Surgical
14
2
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
7.1%
1 terminated out of 14 trials
87.5%
+1.0% vs benchmark
14%
2 trials in Phase 3/4
71%
5 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
TEAPOT Study Multisite
TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study
GATT-Patch Versus TachoSil in Liver Surgery
Effect of Intravenous Tranexamic Acid on Visual Clarity During Shoulder Arthroscopy in the Beach Chair Position
GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery
Effectiveness of Tranexamic Acid in Reducing Blood Loss During Femoral Nail Surgery
Safe and Timely Antithrombotic Removal (STAR) Registry
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
Clinical Safety and Performance of GATT-Patch in Open Liver Surgery
Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery
Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy
Assessment of the Impact of Perioperative Administration of Tranexamic Acid on Bleeding After Sleeve Gastrectomy
Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy